Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a randomized, double-blind, controlled clinical trial is to evaluate the duration of efficacy of parasternal blocks with the use of local anesthetic adjuncts for analgesia after coronary artery bypass grafting surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2021
CompletedFirst Posted
Study publicly available on registry
January 13, 2022
CompletedStudy Start
First participant enrolled
January 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedJune 10, 2024
June 1, 2024
1.3 years
December 3, 2021
June 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain with inspirometry at 24 hours after surgery
Numerical Rating Scale (NRS) pain score from the sternotomy site during inspirometry. The VAS score is a scale from 0 to 10 where 0 is equivalent to "no pain" and 10 is equal to "the worst imaginable pain"
24 hours after surgery
Secondary Outcomes (10)
Opioid consumption
12, 24 and 48 hours after surgery
Amount of rescue analgesia administered
Total in the first 48 hours after surgery
Pain score at rest
12, 24 and 48 hours after surgery
Pain score with inspirometry
12 and 48 hours after surgery
Intensive Care Unit (ICU) Length of Stay
From surgery until discharge from the ICU, assessed from the date of surgery up until 6 months after the completion of the study
- +5 more secondary outcomes
Other Outcomes (9)
Presence of postoperative vomiting
first 48 hours after surgery
Incidence of bradycardia
first 48 hours after surgery
Incidence of hyperglycemia
first 48 hours after surgery
- +6 more other outcomes
Study Arms (2)
Intervention group
EXPERIMENTALPatients will receive bilateral parasternal blocks at the end of cardiac surgery.
Control group
PLACEBO COMPARATORPatients will receive all standard care as per the hospital protocols.
Interventions
Parasternal block with Bupivacaine 0.25% + Epinephrine 1:200,000 x 60cc + Dexamethasone 5mg and Dexmedetomidine 50mcg
All standard management of postoperative pain, as per local protocols
Eligibility Criteria
You may qualify if:
- Patients coming for elective and urgent coronary artery bypass (CABG)-only surgery.
You may not qualify if:
- Patients with a history of regular opioid use.
- Patients with a history of chronic pain.
- Patients unable to provide consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital
Montreal, Quebec, H3T1E2, Canada
Related Publications (1)
Cameron MJ, Long J, Yang SS, Kardash K. How Many Patients Are Needed to Detect a Difference in Pain With Parasternal Blocks? Anesth Analg. 2025 Jul 1;141(1):210-211. doi: 10.1213/ANE.0000000000007355. Epub 2024 Dec 17. No abstract available.
PMID: 39689005DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 3, 2021
First Posted
January 13, 2022
Study Start
January 26, 2022
Primary Completion
April 28, 2023
Study Completion
June 1, 2024
Last Updated
June 10, 2024
Record last verified: 2024-06